Trial NCT00999518

View at ClinicalTrials.gov 
Org. Study IDs: A4091035
Secondary IDs: 2009-014597-17

Last trial update was posted on 2021-08-03

MeSH Interventions

Tanezumab

MeSH Conditions

Cystitis Cystitis, Interstitial

Other Conditions


Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

The study was terminated due to lack of efficacy of all doses of tanezumab demonstrated during pre-planned interim analysis.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID